tm logo

Monitor this mark

View On USPTO

REBOUND THERAPEUTICS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 20 Aug 2024

Last Applicant/ Owned by

Rebound Therapeutics Corporation

13900 Alton Parkway, Suite 125

Irvine

CA

92618

Serial Number

86815157 filed on 10th Nov 2015

Registration Number

5396887 registered on 06th Feb 2018

in the Principal Register

Correspondent Address

Eva Tan

Eva Tan Integra LifeSciences Corporation

Attn: Law Dept./ IP Group

Princeton, NJ 08540

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

REBOUND THERAPEUTICS

Devices for localizing the blood mass of an intracerebral hematoma; devices for extracting an intracerebral hematoma

Classification Information

Class [010]
Medical Instrument Products

Devices for localizing the blood mass of an intracerebral hematoma; devices for extracting an intracerebral hematoma

First Use Date in General

27th Apr 2017

First Use Date in Commerce

27th Apr 2017

Mark Details

Serial Number

No 86815157

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
20th Aug 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Aug 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20th Aug 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05th Feb 2024TEAS SECTION 8 & 15 RECEIVED
06th Feb 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
31st Jan 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
31st Jan 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31st Jan 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31st Jan 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31st Jan 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED